Mark Olfson, MD, MPH

Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University and the New York State Psychiatric Institute, New York, New York

  • 53Articles
  • 315.2KReads
  • 2000–2026Active
  • 150Collaborators
  • 1.9KCitations

About

Mark Olfson, MD, MPH, is affiliated with the Department of Psychiatry at Vagelos College of Physicians and Surgeons, Columbia University, and the New York State Psychiatric Institute in New York. He has authored 53 articles for Psychiatrist.com between 2000 and 2026, focusing on topics such as depression, suicide, addiction, anxiety, psychiatry, schizophrenia, mood disorders, and patient care. Frequent collaborators include Carlos Blanco, Christoph U. Correll, Shuai Wang, Frédéric Limosin, and Melanie M. Wall.

Publications

JCP
Comparing Risk Prediction for Suicide Attempts and Deaths After Emergency Department Visits
Original Research

Comparing Risk Prediction for Suicide Attempts and Deaths After Emergency Department Visits

March 4, 2026

Distinct factors predict nonfatal and fatal suicidal events. Male sex and depression are the strongest predictors for fatal events; being under 65 years of age and suicidal ideation are...
, , , et al
JCP
Trends in Benzodiazepine Prescribing to Adults in the United States
Original Research

Trends in Benzodiazepine Prescribing to Adults in the United States

February 18, 2026

Between 2018 and 2022, annual benzodiazepine use by US adults decreased from 4.7% to 3.4%.
, , , et al
JCP
Prevalence and 3-Year Outcomes of Mood Disorders
Original Research

Prevalence and 3-Year Outcomes of Mood Disorders

November 12, 2025

Lower relapse rates of secondary mood disorders at 3 years suggest a more favorable course when the underlying cause is identified and treated.
, , , et al
JCP
Defense Mechanisms and Common Psychiatric Disorders
Original Research

Defense Mechanisms and Common Psychiatric Disorders

April 28, 2025

Individuals with mood, anxiety, or substance use disorders generally had a higher prevalence of defense mechanisms than those with no disorders. Defense mechanisms and psychiatric disorders represent correlated but...
, , , et al
JCP
Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum
Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

March 5, 2025

Risks of a postpartum suicide attempt were increased 4- to 30-fold by clinical factors, including prenatal suicide attempt ED visits, psychiatric ED visits, and assault ED visits, and by...
, , , et al
JCP
Sex Differences in Antidepressant Acceptability
Original Research

Sex Differences in Antidepressant Acceptability

December 4, 2024

This study provides evidence of sex differences in antidepressant acceptability, with fluoxetine more acceptable for men than women and the reverse true for paroxetine. Findings suggest the importance of...
, , , et al
JCP
Race, Ethnicity, and ED Disposition for Mental Health Visits
Original Research

Race, Ethnicity, and ED Disposition for Mental Health Visits

July 26, 2023

Black patients, especially Black male patients, are overrepresented in inpatient psychiatry. This study examined biases in admission rates among Black patients and, specifically, Black male patients with or without...
,
JCP
Use of Medication With Depressive Symptom Side Effects
Original Research

Use of Medication With Depressive Symptom Side Effects

May 24, 2023

MDD patients who used non-psychiatric medications with depressive side effects had higher odds of experiencing moderate to severe depressive symptoms.
, , , et al
JCP
Sleep Complaints and Risk of Psychiatric Disorders
Original Research

Sleep Complaints and Risk of Psychiatric Disorders

December 21, 2022

Sleep complaints were associated with risk of psychiatric disorders independent of sociodemographic and clinical characteristics in this study of NESARC data.
, , , et al
JCP
Acceptability of Second-Line Antidepressant Medications
Original Research

Acceptability of Second-Line Antidepressant Medications

October 17, 2022

Second-line antidepressant options were ranked according to acceptability (efficacy and tolerability), using data from the French health system.
, , , et al
JCP
Original Research

Remission and Treatment Augmentation of Depression

November 2, 2021

Closer monitoring of symptoms through measurement-based care and setting symptom remission as a goal can help improve outcomes for adults with depression.
, , , et al
JCP
Original Research

Suicide Risk of Mental Health Emergency Patients

October 26, 2021

This study of Medicaid data investigated whether a recent emergency department visit indicates a greater risk of suicide among people with suicidal ideation.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe